Drugs / hDFSCs-Exo
last change Sep 2026 re-read 3 minutes ago

hDFSCs-Exo

Other / unclassified

Developed for
schizophrenia
Investigated by
Chengdu Celincare Biotechnology Co., Ltd. · Zigong Mental Health Center

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT07485751 Mar → Sep 2026 overdue schizophrenia Zigong Mental Health Center Not yet recruiting No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as hDFSCs-Exo ClinicalTrials.gov intervention name — accepted as the source's own label NCT07485751 ↗
Modality Other / unclassified “exosomes derived from human dental follicle mesenchymal stem cells” NCT07485751 ↗
Route Intranasal “Nasal delivery of exosomes derived from human dental follicle mesenchymal stem cells” NCT07485751 ↗